Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Clene Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
06/30/2023 8-K Investor presentation
Docs: " ",
" ",
" "
03/06/2023 8-K Investor presentation
Docs: " "
02/27/2023 8-K Investor presentation
Docs: " "
10/03/2022 8-K Investor presentation
Docs: "Clene Reports Topline Results Demonstrating Survival Signal for CNM-Au8® in Healey ALS Platform Trial • The primary endpoint of adjusted ALSFRS-R and secondary endpoints of CAFS and SVC were not met at 24 weeks • Prespecified exploratory analyses of the secondary survival endpoint for the 30 mg dose demonstrated a >90% reduction in risk of death or risk of death/permanently assisted ventilation at 24 weeks • Survival signal consistent with prior results from the Phase 2 RESCUE-ALS trial • Clene will continue the open-label extension of CNM-Au8 in the Healey ALS Platform Trial and is in discussions with the Healey & AMG ALS Center to design and offer an Expanded Access Protocol of CNM-Au8 30mg for eligible participants of closed regimens and others • Clene...",
"Healey ALS Platform Trial CNM-Au8 Results Webcast October 2022 Exhibit 99.2",
"Corporate Presentation October 2022 Exhibit 99.3 Forward Looking Statements This"
08/15/2022 8-K Quarterly results
07/21/2022 8-K Quarterly results
07/14/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
04/05/2022 8-K Investor presentation
Docs: "Long-Term Survival in OLE Participants:"
03/14/2022 8-K Quarterly results
03/11/2022 8-K Quarterly results
02/15/2022 8-K Investor presentation
Docs: "Investor Contact",
"Q4 2021 Q3 2021 Q1 2022 Q2 2022 Q3"
12/16/2021 8-K Investor presentation
Docs: "CORPORATE PRESENTATION"
12/01/2021 8-K Investor presentation
Docs: "Clene Nanomedicine Presents Updated Data from RESCUE-ALS Phase 2 Study at 4th Annual ALS ONE Research Symposium",
"PRESENTATION DATED NOVEMBER 30, 2021"
11/09/2021 8-K Investor presentation
Docs: "Clene Reports Third Quarter 2021 Operating and Financial Highlights",
"CORPORATE PRESENTATION DATED NOVEMBER 9, 2021"
11/02/2021 8-K Investor presentation
Docs: "Clene Nanomedicine Announces Top-Line Results from Phase 2 RESCUE-ALS Clinical Trial",
"RESCUE-ALS PRESENTATION DATED NOVEMBER 2, 2021"
10/07/2021 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy